t-Hexadecanethiol | 25360-09-2

• 物质功能分类: 化学试剂 - 有机试剂 - 硫醇盐
• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醇
• 英文名称: t-Hexadecanethiol
• 英文别名: 13,13-dimethyltetradecane-1-thiol
• CAS: 25360-09-2
• 化学式: C₁₆H₃₄S
• 分子量: 258.5
• InChiKey: KZIYAWAYDPPPIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.8
• 重原子数：
  17
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2930909090

文献信息

• Antibacterial compound
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030171330A1

  公开（公告）日：2003-09-11

  A compound of formula (I) 1 wherein R 1 and R 2 represent a hydrogen atom or an aryl, a heterocyclic, an alkyl or an alkenyl, which are optionally substituted, R 3 represents a hydrogen atom or a hydroxyl and X 1 and X 2 represent an oxygen atom, a sulfur atom or a nitrogen containing group, a pharmaceutically acceptable derivative thereof or a salt thereof. A pharmaceutical composition comprising the compound for the prevention or treatment of a bacterial infection. A method for the prevention or treatment of a bacterial infection in a warm-blooded animal comprising administering a pharmacologically effective amount of the compound.

  式（I）的化合物，其中R1和R2代表氢原子或芳基、杂环基、烷基或烯基，可以是可选择取代的；R3代表氢原子或羟基；X1和X2代表氧原子、硫原子或含氮基团，其药用上可接受的衍生物或盐。包括该化合物的药物组合物，用于预防或治疗细菌感染。一种方法，用于在温血动物中预防或治疗细菌感染，包括给予该化合物的药理有效量。
• NOVEL A-500359 DERIVATIVES
  申请人：Sankyo Company, Limited

  公开号：EP1209166A1

  公开（公告）日：2002-05-29

  The present invention relates to a compound of formula (I) (wherein R1 and R2 represent an aryl group, a heterocyclic group, an alkyl group, an alkenyl group and the like which are optionally substituted, R3 represents a hydrogen atom or a hydroxyl group, and X1 and X2 represent an oxygen atom or a sulfur atom, or a nitrogen atom which may be substituted), a pharmaceutically acceptable derivative thereof or a salt thereof. The present invention also relates to a pharmaceutical composition comprising a compound described above as an active ingredient for the prevention or treatment of bacterial infections. The present invention includes the use of a compound described above in order to prepare a medicament effective in the prevention or treatment of bacterial infections. The present invention is concerned with a method for the prevention or treatment of bacterial infections in warm-blooded animals comprising administering a pharmacologically effective amount of a compound described above to them.

  本发明涉及一种式(I)化合物（其中 R1 和 R2 代表芳基、杂环基、烷基、烯基等任选被取代的基团，R3 代表氢原子或羟基，X1 和 X2 代表氧原子或硫原子或可被取代的氮原子）、其药学上可接受的衍生物或其盐。 本发明还涉及一种药物组合物，其中包含上述化合物作为活性成分，用于预防或治疗细菌感染。 本发明包括使用上述化合物制备有效预防或治疗细菌感染的药物。 本发明涉及一种预防或治疗温血动物细菌感染的方法，包括给温血动物服用药理有效量的上述化合物。
• Sweetener and flavor compositions, methods of making and methods of use thereof
  申请人：EPC Natural Products Co., Ltd.

  公开号：US11147295B2

  公开（公告）日：2021-10-19

  Sweetener and flavor compositions with improved taste profiles are disclosed. Also disclosed are methods of making and methods of using such sweetener and flavor compositions.

  本发明公开了具有改进口味特征的甜味剂和香料组合物。还公开了制作和使用这种甜味剂和香料组合物的方法。
• Tasteful natural sweetener and flavor
  申请人：EPC Natural Products Co., Ltd.

  公开号：US11154079B2

  公开（公告）日：2021-10-26

  The invention describes products, uses thereof, compositions thereof, and methods to prepare products formed from Maillard reaction products from a sugar donor and/or sweet tea extracts, stevia extracts, swingle (mogroside) extracts, one or more sweet tea extract components, one or more steviol glycosides, one or more mogrosides, one or more glycosylated sweet tea glycosides, one or more glycosylated steviol glycosides or one or more glycosylated mogrosides and an amine donor/reactant.

  本发明描述了由糖供体和/或甜茶提取物、甜叶菊提取物、秋茄（mogroside）提取物、一种或多种甜茶提取物成分、一种或多种甜菊醇苷、一种或多种mogrosides、一种或多种糖基化甜茶苷、一种或多种糖基化甜菊醇苷或一种或多种糖基化mogrosides和胺供体/反应物的Maillard反应产物形成的产品、其用途、其组合物和制备方法。
• SWEETENER AND FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF
  申请人：EPC Natural Products Co., Ltd.

  公开号：EP3790407A1

  公开（公告）日：2021-03-17